-
-
Preoperative stratification of cytologically indeterminate thyroid nodules by [18F]FDG-PET
-
-
A clinically applicable molecular classification of oncocytic cell thyroid nodules
-
-
[F-18]FDG uptake and expression of immunohistochemical markers related to glycolysis, hypoxia, and proliferation in indeterminate thyroid nodules
-
-
[18F]FDG uptake and expression of immunohistochemical markers related to glycolysis, hypoxia, and proliferation in indeterminate thyroid nodules
-
-
Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
-
-
FDG-PET/CT in indeterminate thyroid nodules
-
-
Quantitative classification and radiomics of [F-18]FDG-PET/CT in indeterminate thyroid nodules
-
-
[F-18]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules
-
-
In reaction to: Thuillier P, Benisvy D, Ansquer C, Corvilain B, Mirallie E, Taieb D, et al. Section 5: What is the role of functional imaging and isotopic treatment? Ann Endocrinol (Paris) 2022;83:401-6. https://doi.org/10.1016/j.ando.2022.10.008
-
-
Radioiodine in differentiated thyroid carcinoma
-
-
F-18-FDG PET and F-18-FDG PET/CT in Vulvar Cancer A Systematic Review and Meta-analysis
-
-
Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules
-
-
Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules
-
-
Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings
-
-
Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings
-
-
Meta-analysis of 99mTc-Sestamibi Imaging for Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer: More Consistent Results by Incorporating Standardized Quantification, SPECT/CT and Tumour Subtypes?
